| mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.04 |
| mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.05 |
| mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
| mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.05 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.05 |
| mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
| mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.05 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.05 |
| mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.05 |